Fitness & Wellness Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness & Wellness Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bone Research
Research in the area of bone research reported from T. Hertrampf and colleagues
May 21st, 2008
A new study, 'Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized rats,' is now available. According to a study from Cologne, Germany, "Studies with oestrogen receptoralpha (ERalpha)-and ERbeta-selective compounds have already shown that the effects of 17beta-estradiol (E2) on body weight, movement drive and bone-protection are mediated via ERalpha. This study was based on the hypothesis that activation of ERbeta may antagonize ERalpha-mediated effects and designed to investigate potential effects of ERalpha/ERbeta heterodimers." "EXPERIMENTAL APPROACH: Ovariectomized (OVX) female Wistar rats...
Source: Fitness & Wellness Business Week (2008-05-21)
|
